UniSa - IRIS Institutional Research Information System

ESPOSITO, Carla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.147
AS - Asia 4.985
EU - Europa 2.672
SA - Sud America 383
Continente sconosciuto - Info sul continente non disponibili 213
AF - Africa 54
OC - Oceania 7
Totale 16.461
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.986
HK - Hong Kong 2.230
SG - Singapore 1.156
IT - Italia 955
CN - Cina 785
UA - Ucraina 497
VN - Vietnam 393
BR - Brasile 294
DE - Germania 275
RU - Federazione Russa 225
FI - Finlandia 173
FR - Francia 147
IE - Irlanda 140
TR - Turchia 88
SE - Svezia 79
KR - Corea 78
GB - Regno Unito 76
IN - India 65
CA - Canada 63
MX - Messico 58
BD - Bangladesh 32
AR - Argentina 28
IQ - Iraq 25
JP - Giappone 25
ZA - Sudafrica 22
ES - Italia 19
PL - Polonia 19
CO - Colombia 18
CZ - Repubblica Ceca 13
ID - Indonesia 13
PK - Pakistan 13
VE - Venezuela 13
PH - Filippine 12
CL - Cile 11
JM - Giamaica 11
SA - Arabia Saudita 11
JO - Giordania 10
UZ - Uzbekistan 10
MA - Marocco 9
NL - Olanda 8
CR - Costa Rica 7
IL - Israele 7
AT - Austria 6
MY - Malesia 6
RS - Serbia 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
HN - Honduras 5
KE - Kenya 5
LT - Lituania 5
PE - Perù 5
AL - Albania 4
AU - Australia 4
BO - Bolivia 4
BY - Bielorussia 3
ET - Etiopia 3
HU - Ungheria 3
KZ - Kazakistan 3
PY - Paraguay 3
RO - Romania 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AO - Angola 2
BB - Barbados 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GR - Grecia 2
KG - Kirghizistan 2
MN - Mongolia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
TH - Thailandia 2
TW - Taiwan 2
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BW - Botswana 1
CG - Congo 1
CH - Svizzera 1
CY - Cipro 1
DJ - Gibuti 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
GP - Guadalupe 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MG - Madagascar 1
Totale 16.236
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.221
Ann Arbor 1.338
San Jose 713
Wilmington 692
Chandler 619
Jacksonville 600
Singapore 591
Dallas 524
Princeton 393
Ashburn 359
Milan 275
Houston 271
Council Bluffs 218
Dong Ket 210
Woodbridge 209
Beijing 174
Munich 139
Dublin 137
Boardman 111
Nanjing 110
Dearborn 107
The Dalles 99
Andover 97
Lauterbourg 93
Pellezzano 76
Ho Chi Minh City 70
Salerno 65
Izmir 62
Los Angeles 61
Rome 59
Helsinki 58
Mestre 49
Moscow 49
Santa Clara 43
Fairfield 41
Hanoi 40
New York 39
Redwood City 37
São Paulo 37
Figino 35
Nanchang 35
Hebei 33
Shenyang 33
Changsha 27
Orem 26
Montreal 25
Tokyo 25
Tianjin 21
Jiaxing 20
Pune 20
Warsaw 19
Brooklyn 18
Chicago 18
Phoenix 17
Washington 17
Chennai 16
London 16
Memphis 16
Napoli 16
Sant'agata De' Goti 16
Cuauhtémoc 14
Stockholm 14
Agropoli 13
Bologna 13
Istanbul 13
Johannesburg 13
Manchester 13
San Diego 13
Belo Horizonte 12
Brno 12
Frankfurt am Main 12
Norwalk 12
Seattle 12
Turku 12
Cava 11
Düsseldorf 11
Guangzhou 11
Ottawa 11
Philadelphia 11
Medellín 10
Naples 10
Tashkent 10
Amman 9
Atlanta 9
Bari 9
Boston 9
Da Nang 9
Denver 9
Lessolo 9
Mexico City 9
Poplar 9
San Francisco 9
Haiphong 8
Potenza 8
Rio de Janeiro 8
Spinea 8
Baghdad 7
Buffalo 7
Caserta 7
Columbus 7
Totale 11.968
Salva come PNG Salva come JPEG
Nome #
Searching for the protein targets of 4-nonylphenol using a computational approach 724
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells 658
A preliminary study on nonylphenol toxicity in human intestinal epithelial cells 596
The surfactant 4-nonylphenol is cytotoxic for cells of the human gastrointestinal tract. 354
Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases. 293
Searching for the protein targets of 4-nonylphenol using a computational approach 270
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease. 267
Analysis of transglutaminase protein substrates by functional proteomics. 238
4-Nonylphenol reduces cell viability and induces apoptosis and ER-stress in a human epithelial intestinal cell line 213
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca(2+) homeostasis 210
Celiac anti‑type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects 206
An acetic acid-based extraction method to obtain high quality collagen from archeological bone remains 205
Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease 200
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells 198
Application of a computational approach to identify protein targets for 4-nonylphenol 187
Antibodies against type 2 transglutaminase modulate actin rearrangements and cell cycle in several cell lines 186
The toxic alpha-gliadin peptide 31-43 enters cells without a surface membrane receptor 179
Celiac autoantibodies to tissue transglutaminase modulate alpha-gliadin peptide uptake by epithelial cells 177
Autoantibodies to tissue transglutaminase can induce ER (endoplasmic reticulum) stress response in Caco-2 cells 175
Interaction of 'toxic' and 'immunogenic' A-gliadin peptides with a membrane-mimetic environment 174
A-gliadin peptide 31-43 induces NF-κB and tissue transglutaminase activation in an intestinal epithelial cell line 173
THE A-GLIADIN PEPTIDE 31-43 INDUCES NF-kB ACTIVATION AND MODULATE TYPE 2 TRANSGLUTAMINASE ACTIVITY IN AN INTESTINAL EPITHELIAL CELL LINE 173
Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics 173
Synthesis of peptidocalix[4]arene diversomers as transglutaminase inhibitors by protein surface recognition 169
ANTI-TISSUE TRANSGLUTAMINASE ANTIBODIES ACTIVATE CYTOSOLIC TISSUE TRANSGLUTAMINASE BY MOBILIZING CALCIUM IONS FROM INTRACELLULAR STORES 167
A-GLIADIN PEPTIDES INDUCE TISSUE TRANSGLUTAMINASE ACTIVATION THROUGH CA2+ MOBILIZATION IN CACO-2 CELLS 167
Anti-Tissue Transglutaminase Antibodies from Coeliac Patients Inhibit Transglutaminase Activity both in Vitro and in Situ 165
Enzymatic Strategies to Detoxify Gluten:Implications for Celiac Disease 165
Identification of differential phosphorylated proteins in Caco-2 cells treated with anti-tissue transglutaminase antibodies 165
Gliadin Peptides Induce Tissue Transglutaminase Activation and ER-Stress through Ca(2+) Mobilization in Caco-2 Cells. 162
Chronic Exposure to Cadmium Disrupts the Adrenal Gland Activity of the Newt Triturus carnifex (Amphibia, Urodela) 158
Tissue transglutaminase in celiac disease: role of autoantibodies. 156
Mammalian Transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance. 155
Biochemical characterization of recombinant rat prostate transglutaminase expressed into MDCK cells 153
Caratterizzazione della transglutaminasi da prostata di ratto espressa in cellule MDCK 150
Anti-tissue transglutaminase antibodies have biological effects on cultured intestinal biopsies from celiac patients 150
Constitutive differential features of type 2 transglutaminase in cells derived from celiac patients and from healthy subjects 150
Internalization of alpha gliadin peptide 31-43 by Caco-2 cells does not require a surface receptor. 143
Celiac anti-tissue transglutaminase autoantibodies interfere with the ability of alpha-gliadin peptide 31-43 to drive intestinal epithelial cells into S-phase. 142
Subcellular distribution of type 2 transglutaminase is constitutively different in skin derived-fibroblasts from celiac disease patients and from healthy controls 142
N-terminus end of rat prostate transglutaminase is responsible for its catalytic activity and GTP binding 142
Serum IgA and IgG and intestinal monoclonal anti-tissue transglutaminase antibodies from coeliac patients inhibit the catalytic activity both in vitro and in situ. 141
Expression and enzymatic activity of small intestinal tissue transglutaminase in coeliac disease 141
Histological changes, apoptosis and metallothionein levels in Triturus carnifex (Amphibia, Urodela) exposed to environmental cadmium concentrations 140
Type 2 transglutaminase contributes to define a cellular phenotype typical of celiac cells. 140
New therapeutic strategies for coeliac disease: tissue transglutaminase as a target 139
Celiac anti-tissue transglutaminase antibodies derange alpha gliadin peptide 31-43 uptake by epithelial cells. 138
Transglutaminase surface recognition by peptidocalix[4]arene diversomers. 133
Tissue transglutaminase autoantibodies regulate actin rearrangements and cell cycle in several cell types 133
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies. 133
The monoclonal anti-tissue transglutaminase antibody CUB 7402 reduces the alpha-gliadin peptides uptake by Caco-2 cells 133
Tissue Transglutaminase and Coeliac Disease. 132
Proteomics identification of acyl-acceptor and acyl-donor substrates for transglutaminase in a human intestinal epithelial cell line: implications for coeliac disease. 126
Tissue transglutaminase modulators regulate actin rearrangements and cell cycle in several cell types 125
Transglutaminase surface recognition by peptidocalix[4]arene diversomers 125
Expression and Enzymatic Activity of Small Intestinal Tissue Transglutaminase in Coeliac Disease 124
Seminal Vesicle Protein IV and Its Derived Active Peptides: A Possible Physiological Role in Seminal Clotting. 124
Transglutaminase 2 in celiac diasease: Minireview article 123
Interplay between type 2 transglutaminase (Tg2), gliadin peptide 31-43 and anti-tg2 antibodies in celiac disease 123
Riconoscimento di superficie delle transglutamminasi mediante diversomeri peptidocalix[4]arenici 122
Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate deydrogenase and polyglutamine repeat. 122
Tissue transglutaminase is implicated in the antiproliferative and proapoptotic effect induced by the histone deacetylase inhibitor 121
Studi di specificità di isoforme dell'enzima transglutaminasi per modificare proteine del latte 119
Influenza delle modifiche post-traduzionali sulle proprietà biologiche della TGasi presente nel secreto della ghiandola coagulatoria 117
Non celiac patients’ anti-tissue transglutaminase antibodies: immunological and functional characterization. 116
Characterisation of rat coagulating gland transglutaminase expressed in heterologous cell systems 115
Implication of cell-surface transglutaminase in gliadin peptides uptake by Caco-2 cells 114
The Pituitary-adrenal gland Activity of Triturus carnifex (Amphibia, Urodela) exposed to Environmental Cadmium Concentrations 114
The mechanism of cytotoxicity of 4-nonylphenol in a human hepatic cell line involves ER-stress, apoptosis, and mitochondrial dysfunction 114
GTPase and transglutaminase are associated in the secretion of rat anterior prostate. 113
Identification of acyl-acceptor and acyl-donor substrates for transglutaminase in CaCo-2 intestinal cell line: implications for coeliac disease 112
Effects of Methyl Bromide on activity of blood coagulation enzymes 112
Serum immunoglobulin A and G and monoclonal antibodies anti tissue-transglutaminase from coeliac patients inhibit the catalytic activity both in vitro and in situ. 111
Transglutaminase-synthesized spermine derivative of substance P recognizes rat portal vein neurokinin-3 receptors. 109
Interaction of “toxic” and “immunogenic” A-gliadin peptides with a membrane-like environment in vitro. 107
Studio del riconoscimento tra transglutaminasi di tipo 2 e auto-anticorpi anti-transglutaminasi caratteristici della malattia celiaca 106
Tissue transglutaminase autoantibodies regulate actin rearrangements and cell cycle in several cell types. 105
Role of type 2 transglutaminase autoantibodies in phatogenesis of celiac disease 105
Do tissue transglutaminase antibodies contribute to the intestinal lesion in celiac disease? 104
Transglutaminase-mediated amine incorporation into substance P protects the peptide against proteolysis in vitro. 103
Implication of tissue transglutaminase and desmoplakin in cell adhesion mechanism in human epidermis 103
Rat coagulating gland secretion contains a kinesin heavy chain-like protein acting as type IV transglutaminase substrate 103
Overlapping between fluorescence modifications and activation of prostate transglutaminase induced by sodium dodecylsulphate. 102
Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells 101
Studies on transglutaminase type IV in relation to proteins occuring in rat coagulating gland secretion 100
null 98
Transglutaminase-synthesized analogs of substance P is a selective tool for neurokinin-2 receptors. 97
Expression and enzymatic activity of transglutaminase in the normal and coeliac small intestinal mucosa 97
Espressione e attività enzimatica della transglutaminasi tissutale nella mucosa intestinale di pazienti celiaci 97
Enzymatic synthesis of vasoactive intestinal peptide analogs by transglutaminase. 94
Substance P and its transglutaminase-synthesized spermine derivative elicit yawning behavior via nitric oxide in rats. 94
Identification of tissue transglutaminase protein substrates in Caco-2 cells 94
Identification of tissue transglutaminase-reactive lysine residues in glyceraldheide-3-phosphate dehydrogenase 92
Transglutaminase-mediated polyamination of vasoactive intestinal peptide (VIP) Gln16 residue modulates the VIP/PACAP receptor activity. 91
Structural characterisation of transglutaminase-catalysed protein aggregates correlated to neurodegenerative disorders. 90
Desmoplakin acts as transglutaminase substrate in vitro. 89
Identification of tissue transglutaminase protein substrates in Caco-2 cells 89
Protein SV-IV promotes nitric oxide production not associated with apoptosis in murine macrophages. 87
Coeliac disease and extraintestinal autoimmunity. 87
IgA e IgG sieriche e anticorpi monoclonali intestinali anti-transglutaminasi tissutale ottenuti da pazienti celiaci inibiscono l'attività catalitica sia in vitro che in situ 87
Totale 15.656
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.448
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022765 0 0 0 2 40 13 1 25 114 87 121 362
2022/20231.343 134 103 31 176 186 260 0 166 196 0 64 27
2023/2024465 48 68 33 21 38 81 23 31 0 26 19 77
2024/20251.308 62 27 54 88 58 147 268 146 183 33 112 130
2025/20266.478 540 980 1.501 330 592 272 690 135 303 533 121 481
2026/2027791 150 156 377 108 0 0 0 0 0 0 0 0
Totale 16.461